Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients
- PMID: 38009102
- PMCID: PMC10668572
- DOI: 10.12688/f1000research.73476.3
Mutation spectrum analysis of DMD gene in Indonesian Duchenne and Becker muscular dystrophy patients
Abstract
Background: Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are allelic disorders caused by mutations in the DMD gene. The full mutation spectrum of the DMD gene in Indonesian patients is currently unknown. Mutation-specific therapies are currently being developed, such as exon skipping or stop codon read-through therapy. This study was conducted with the aim of identifying the mutation spectrum of the DMD gene in Indonesia to guide future development and application of feasible therapeutic strategies.
Methods: This study is a cross sectional study that enrolled 43 male patients with a clinical suspicion of DMD or BMD. Multiplex ligation-dependent probe amplification (MLPA) reaction was performed to screen for the common mutations in the DMD gene.
Results: Out of 43 subjects, deletions accounted for 69.77% (n=30) cases, while duplications were found in 11.63% (n=5) cases. One novel duplication spanning exons 2 to 62 was identified. Deletion mutations clustered around the distal (66.67%) and proximal (26.67%) hot spot regions of the DMD gene while duplication mutations were observed solely at the proximal region. Two false positive cases of single exon deletion detected through MLPA were attributed to sequence mutations affecting primer ligation sites, confirming the need to validate all single exon deletions when using this screening method. Analysis of available maternal DNA samples showed that the rate of de novo mutations (48.15%) appears higher than expected in this population. Out of 31 patients who were classified as DMD based on clinical and genotype characterizations, 60.47% (n=26) of cases were suitable for exon skipping therapy.
Conclusion: This is the first comprehensive study showing the feasibility of implementing the MLPA method for routine screening of DMD patients in Indonesia. This is also the first study showing the potential applicability of exon skipping therapy in the majority of DMD cases in the country.
Keywords: Becker muscular dystrophy; DMD gene; Duchenne muscular dystrophy; Indonesia; MLPA; mutation analysis.
Copyright: © 2023 Dwianingsih EK et al.
Conflict of interest statement
No competing interests were disclosed.
Figures




Similar articles
-
Multiplex Ligation-Dependent Probe Amplification in X-linked Recessive Muscular Dystrophy in Korean Subjects.Yonsei Med J. 2017 May;58(3):613-618. doi: 10.3349/ymj.2017.58.3.613. Yonsei Med J. 2017. PMID: 28332368 Free PMC article.
-
Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy.BMC Med Genet. 2019 Aug 14;20(1):139. doi: 10.1186/s12881-019-0873-0. BMC Med Genet. 2019. PMID: 31412794 Free PMC article.
-
Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis.Indian J Med Res. 2010 Sep;132:303-11. Indian J Med Res. 2010. PMID: 20847377
-
MLPA Analyses Reveal a Spectrum of Dystrophin Gene Deletions/Duplications in Pakistani Patients Suspected of Having Duchenne/Becker Muscular Dystrophy: A Retrospective Study.Genet Test Mol Biomarkers. 2019 Jul;23(7):468-472. doi: 10.1089/gtmb.2018.0262. Epub 2019 May 31. Genet Test Mol Biomarkers. 2019. PMID: 31157985 Review.
-
An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database.Genes (Basel). 2024 Nov 20;15(11):1489. doi: 10.3390/genes15111489. Genes (Basel). 2024. PMID: 39596689 Free PMC article. Review.
References
-
- Wedhanto S, Siregar UP: Duchenne muscular dystrophy. Majalah Kedokteran Indonesia. 2007;57(9):312.
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources